vs
KKR Real Estate Finance Trust Inc.（KREF）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是KKR Real Estate Finance Trust Inc.的1.4倍（$35.5M vs $25.8M），KKR Real Estate Finance Trust Inc.净利率更高（-101.7% vs -304.2%，领先202.5%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -26.6%），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -18.8%）
KKR房地产金融信托公司是全球投资机构KKR旗下的专业房地产金融平台，主要发起、收购并管理优先担保商业地产贷款组合，抵押物多为美国各地的优质机构级商业地产，通过贷款利息收入为投资者提供稳定的经风险调整后的回报。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
KREF vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $25.8M | $35.5M |
| 净利润 | $-26.2M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | -105.1% | -304.8% |
| 净利率 | -101.7% | -304.2% |
| 营收同比 | -26.6% | 681.7% |
| 净利润同比 | -229.6% | 39.6% |
| 每股收益（稀释后） | $-0.49 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $25.8M | $35.5M | ||
| Q3 25 | $25.3M | $5.2M | ||
| Q2 25 | $30.2M | $19.2M | ||
| Q1 25 | $31.3M | $14.7M | ||
| Q4 24 | $35.1M | $4.5M | ||
| Q3 24 | $37.0M | $26.1M | ||
| Q2 24 | $40.4M | $14.4M | ||
| Q1 24 | $39.1M | $13.8M |
| Q4 25 | $-26.2M | $-108.1M | ||
| Q3 25 | $13.8M | $-162.3M | ||
| Q2 25 | $-29.7M | $-171.9M | ||
| Q1 25 | $-4.9M | $-202.5M | ||
| Q4 24 | $20.3M | $-178.9M | ||
| Q3 24 | $-7.4M | $-95.8M | ||
| Q2 24 | $25.8M | $-97.5M | ||
| Q1 24 | $-3.1M | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | -105.1% | -304.8% | ||
| Q3 25 | 50.4% | -3327.6% | ||
| Q2 25 | -101.3% | -916.8% | ||
| Q1 25 | -18.3% | -1297.9% | ||
| Q4 24 | 55.8% | -4042.4% | ||
| Q3 24 | -19.6% | -377.1% | ||
| Q2 24 | 63.3% | -697.4% | ||
| Q1 24 | -8.7% | -698.4% |
| Q4 25 | -101.7% | -304.2% | ||
| Q3 25 | 54.4% | -3135.3% | ||
| Q2 25 | -98.5% | -894.2% | ||
| Q1 25 | -15.5% | -1373.3% | ||
| Q4 24 | 57.7% | -3935.5% | ||
| Q3 24 | -20.0% | -367.5% | ||
| Q2 24 | 63.9% | -676.6% | ||
| Q1 24 | -7.9% | -662.4% |
| Q4 25 | $-0.49 | $-0.17 | ||
| Q3 25 | $0.12 | $-0.36 | ||
| Q2 25 | $-0.53 | $-0.41 | ||
| Q1 25 | $-0.15 | $-0.50 | ||
| Q4 24 | $0.22 | $-0.56 | ||
| Q3 24 | $-0.19 | $-0.34 | ||
| Q2 24 | $0.29 | $-0.40 | ||
| Q1 24 | $-0.13 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $84.6M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $1.2B | $1.1B |
| 总资产 | $6.5B | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $84.6M | $743.3M | ||
| Q3 25 | $204.1M | $659.8M | ||
| Q2 25 | $107.7M | $525.1M | ||
| Q1 25 | $106.4M | $500.5M | ||
| Q4 24 | $104.9M | $594.4M | ||
| Q3 24 | $108.8M | $427.6M | ||
| Q2 24 | $107.2M | $474.3M | ||
| Q1 24 | $106.5M | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $1.2B | $1.1B | ||
| Q3 25 | $1.2B | $1.0B | ||
| Q2 25 | $1.2B | $919.1M | ||
| Q1 25 | $1.3B | $933.9M | ||
| Q4 24 | $1.3B | $1.0B | ||
| Q3 24 | $1.4B | $524.6M | ||
| Q2 24 | $1.4B | $584.4M | ||
| Q1 24 | $1.4B | $401.2M |
| Q4 25 | $6.5B | $1.5B | ||
| Q3 25 | $6.5B | $1.4B | ||
| Q2 25 | $6.8B | $1.3B | ||
| Q1 25 | $6.6B | $1.3B | ||
| Q4 24 | $6.4B | $1.4B | ||
| Q3 24 | $6.8B | $726.5M | ||
| Q2 24 | $7.1B | $775.9M | ||
| Q1 24 | $7.3B | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $72.3M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-47.3M |
| 自由现金流率自由现金流/营收 | — | -133.1% |
| 资本支出强度资本支出/营收 | — | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $72.3M | $-46.1M | ||
| Q3 25 | $18.5M | $-117.4M | ||
| Q2 25 | $21.1M | $-76.4M | ||
| Q1 25 | $15.9M | $-132.0M | ||
| Q4 24 | $132.6M | $-115.4M | ||
| Q3 24 | $49.1M | $-59.2M | ||
| Q2 24 | $30.6M | $-82.2M | ||
| Q1 24 | $34.5M | $-102.3M |
| Q4 25 | — | $-47.3M | ||
| Q3 25 | — | $-117.6M | ||
| Q2 25 | — | $-79.6M | ||
| Q1 25 | — | $-133.8M | ||
| Q4 24 | — | $-116.7M | ||
| Q3 24 | — | $-63.8M | ||
| Q2 24 | — | $-83.4M | ||
| Q1 24 | — | $-109.0M |
| Q4 25 | — | -133.1% | ||
| Q3 25 | — | -2272.5% | ||
| Q2 25 | — | -413.9% | ||
| Q1 25 | — | -907.4% | ||
| Q4 24 | — | -2567.7% | ||
| Q3 24 | — | -244.6% | ||
| Q2 24 | — | -578.5% | ||
| Q1 24 | — | -789.9% |
| Q4 25 | — | 3.5% | ||
| Q3 25 | — | 4.7% | ||
| Q2 25 | — | 16.4% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | — | 28.6% | ||
| Q3 24 | — | 17.5% | ||
| Q2 24 | — | 8.2% | ||
| Q1 24 | — | 48.2% |
| Q4 25 | — | — | ||
| Q3 25 | 1.34× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.54× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.19× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
